SA
GLAXF logo
GSK plc(GLAXF)
Last print unknown agoAbout this dataData status
$23.40▼-1.05 (-4.29%)Stale · unknown old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 29.7 · elevated volatility

Overview →

GSK plc (GLAXF)

R&D to Revenue

22.98%

Fiscal year · Period ending:

GLAXF logo

GLAXF R&D to Revenue

Latest reported22.98%
GLAXF FY R&D/Revenue (7.91% → 22.98%)
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

GLAXF r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

GSK plc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
22.9834%
17.5198%
17.2942%
16.4916%
17.76%
13.1353%
12.5763%
11.8685%
12.8039%
12.4816%
14.2959%
14.4962%
12.9636%
13.1928%
13.4553%
15.1557%
14.0052%
14.7216%
14.3335%
14.8848%
14.4783%
14.5302%
13.0171%
13.6715%
12.4715%
13.972%
14.947%
14.5685%
14.386%
13.9192%
14.6806%
0%
15.1697%
14.9899%
14.5264%
13.9829%
13.2117%
12.5681%
11.1705%
8.5583%
7.9076%

Frequently asked questions: GLAXF r&d to revenue

What is GSK plc (GLAXF)'s current r&d to revenue?

GSK plc (GLAXF)'s latest reported r&d to revenue (Fiscal year) is 22.98% as of Dec 31, 2025. R&D spending as percentage of revenue.

How much historical r&d to revenue data is available for GLAXF?

Stock Alarm Pro provides 41 dated annual fiscal periods observations for GSK plc (GLAXF)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare GLAXF's r&d to revenue to peers or set an alert?

You can open GLAXF's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on GLAXF delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.